
No link between diabetes drug and rise in heart attacks
A recent study has discarded any link between increase in heart attacks and the intake of the diabetes drug rosiglitazone. The clinical trial of 2,368 diabetes patients with cardiovascular disease, reported no increased rate of heart attack or death in
3 min read



